Butea superba Roxb.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Family | Papilionaceae; Fabaceae. |
| Habitat | Central and Southern India. |
| Ayurvedic | Lataa-Palaash (orange or orange scarlet-flowered var.). |
| Action | Seeds—sedative and anthelmintic; decoction emollient and used topically for piles. Seed oil—anthelmintic and hypotensive. Seeds exhibit haemagglutinating activity against human ABO red cells. Roots—hypotensive. Watery sap from stems is used for drinking purposes. Bark is used in tonics and elixirs. |
| Taxonomic Cohort | Genus Butea (2 documented species); Family Papilionaceae (67 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Butea superba (taxonomically cited with authority Roxb.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Papilionaceae; Fabaceae (primary family classification: Papilionaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: Central and Southern India.
Across classical and vernacular Indian systems of medicine, Butea superba is recognized under distinct polyglot nomenclature: in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Lataa-Palaash (orange or orange scarlet-flowered var.). Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Butea superba are: Seeds—sedative and anthelmintic; decoction emollient and used topically for piles. Seed oil—anthelmintic and hypotensive. Seeds exhibit haemagglutinating activity against human ABO red cells. Roots—hypotensive. Watery sap from stems is used for drinking purposes. Bark is used in tonics and elixirs. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Butea superba establish the following evidence base: White-flowered var. is equated with Butea parviflora Roxb.

Botanical Reference 1: Butea superba — Botanical specimen

Botanical Reference 2: Butea superba — Botanical specimen

Botanical Reference 3: Butea superba — Wikimedia Commons reference
4. Comparative Genus & Family Pharmacognosy
Taxonomically, the genus Butea comprises 2 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Butea monosperma (Action: Bark—astringent, styptic (prescribed in bleeding piles, ulcers, haemorrhages…). Comparing Butea superba alongside its congeners in genus Butea highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.
At the family level, Papilionaceae encompasses 67 documented medicinal species (3.69% of the 1,814-species flora). Other representative medicinal members of Papilionaceae include: Abrus precatorius Linn. (Gunjaa), Alhagi pseudalhagi (Yavaasaka), Arachis hypogaea (Mandapi), Atylosia goensis (Maashaparni), Cajanus cajan (Aadhaki). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 1: Quantitative documentation profile across all 67 medicinal species of family Papilionaceae.
5. Pharmacopoeial Standards, Posology & Reference Framework
In clinical and traditional dispensing, preparation and administration of Butea superba follow the plant-part modalities specified under its therapeutic action (Seeds—sedative and anthelmintic; decoction emollient and used topically for piles. Seed oil—anthelmintic and hypotensive. Seeds exhibit haemagglutinating activity against human ABO red cells. Roots—hypotensive. Watery sap from stems is used for drinking purposes. Bark is used in tonics and elixirs), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Butea superba integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.